Life-style Changes in Obstructive Sleep Apnea

November 6, 2017 updated by: Uppsala University

Health Behaviour Modifications in Obstructive Sleep Apnea. Tailored Behavioural Medicine Strategies to Promote Physical Activity and Weight Loss.

The primary aim is to study whether a tailored behavioural medicine intervention addressing physical activity and eating habits have additional effects to continuous positive airways pressure (CPAP) in patients with moderate or severe obstructive sleep apnea syndrome (OSAS) combined with obesity. Direct everyday life consequences (see below) of OSAS are studied, as well as cognitive functions and ventilatory parameters. Long-term benefits will be examined in terms of quality of life and everyday life activity. Another aim is to study mechanisms of treatment effects, if any.

The specific goals are:

  1. To study changes in OSAS ventilatory parameters following a tailored behavioural medicine intervention addressing physical activity and eating habits (including CPAP) compared to regular CPAP-treatment
  2. To study immediate and long-term effects on daytime sleepiness, attention and concentration, everyday life activity, quality of life following a tailored behavioural medicine intervention addressing physical activity and eating habits (including CPAP) compared to regular CPAP-treatment
  3. To study associations of changes in metabolic parameters and systemic inflammation and physical activity level and adherence to CPAP-regimen respectively.
  4. To identify mediators, moderators, and predictors of treatment effects, if any.

Study Overview

Detailed Description

OSAS is characterised by loud snoring, upper airway obstruction, and occasional apnea during sleep. OSAS may affect at least 4% of the men and 2% of the women in middle-age. In Sweden, prevalence figures of 200 000 have been reported. The mechanisms behind OSAS is not fully explained but functionally impaired upper airways muscles, causing a reduction in tonic and phasic contraction during sleep, are proposed one key explanation. The reduced contractions cause partial or complete occlusion of airflow, which in turn cause oxygen desaturation and sleep fragmentation. Patients commonly report everyday life consequences including loud snoring, sleep disturbances, daytime sleepiness, reduced alertness and concentration, and involvement in motor vehicle accidents. Between 7% and 70% of patients suffer from depression and anxiety (figures vary extensively because of methodological differences in existing studies). Due to cardiovascular consequences, OSAS is also linked to hypertension, myocardial infarction, and stroke. Approximately 75% of patients with severe OSAS carry overweight. First line measures recommended for OSAS are conservative including lifestyle modifications, CPAP, and oral appliances. Current state-of-science concludes that CPAP is best possible evidence-based treatment. Despite the use of life style modification recommendations in terms of physical activity and weight loss in accepted guidelines of OSAS, randomised clinical trials supporting these recommendations are rare. Hence, the value of health behaviour modifications has yet to be established. Research within this area is therefore of major interest and urgency, which has motivated the present study design.

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Uppsala, Sweden, 751 24
        • Uppsala University and University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Moderate or severe obstructive sleep apnea syndrome (AHI/DI>15)
  • BMI>30
  • Literate in Swedish language

Exclusion Criteria:

  • Physically active patients (walking, bicycling for more than 30 minutes per day,during more than 5 days per week)
  • Cardiovascular diseases including myocardial infarctions and stroke
  • Patients on waiting list for gastric by-pass

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tailored behavioural treatment and CPAP
Tailored behavioural treatment targeting physical activity and eating habits.

8-10 sessions, 2-4 booster sessions Behavioural protocol in seven steps to initiate, carry out and maintain health-enhancing physical activity and sound eating habits.

Steps are standardized including: progressive goal setting, self-monitoring, functional behavioural analysis, skills training (basic and applied), generalization, and maintenance and relapse prevention. Content within each step is tailored to individual expectations and skills.

Treatments are provided by a physical therapist and a dietician.

Active Comparator: CPAP-treatment
CPAP-treatment as usual. Advice about benefits of physical activity and weight loss.
CPAP-treatment as usual (during nights)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ventilatory parameters
Time Frame: Baseline, immediate post-treatment, 18-month follow-up

Ventilatory monitoring at night. Oxygen saturation continuously measured by a pulse oximeter. The following parameters are analysed:

  • desaturation index
  • apnoea-hypnoea index
  • average oxygen saturation during sleep
  • minimum oxigen saturation
  • respiration
  • thoracic respiratory movements
  • snoring
  • heart rate
  • body position
Baseline, immediate post-treatment, 18-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Daytime sleepiness
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
Epworths sleepiness scale
Baseline, immediate post-treatment, 18-month follow-up
Attention and concentration
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
  • COWAT
  • Repetition of figures from WAIS
Baseline, immediate post-treatment, 18-month follow-up
Health-related quality of life
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
SF-36
Baseline, immediate post-treatment, 18-month follow-up
Patients' priorities of daily activities and participation
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
The Patient Goal Priority Questionnaire
Baseline, immediate post-treatment, 18-month follow-up
Physical activity
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
  • Sensewear armband
  • Physical activity diary
Baseline, immediate post-treatment, 18-month follow-up
Functional physical capacity
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
6 minutes walking distance
Baseline, immediate post-treatment, 18-month follow-up
Eating behaviour
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
Dutch eating behaviour questionnaire
Baseline, immediate post-treatment, 18-month follow-up
Self-efficacy and readiness to change behaviour
Time Frame: Baseline, mid-treatment, immediate post-treatment, 18-month follow-up
  • Exercise self-efficacy scale
  • Self-efficacy for sound eating habits
  • Readiness to change behaviour
Baseline, mid-treatment, immediate post-treatment, 18-month follow-up
Anthropometrics
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
  • BMI
  • Waist measurement
  • Neck circumference
Baseline, immediate post-treatment, 18-month follow-up
Depression
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
MADRS Depression scale
Baseline, immediate post-treatment, 18-month follow-up
Fear of movement
Time Frame: Baseline, mid-treatment, immediate post-treatment, 18-month follow-up
Selected items from the Tampa Scale of Kinesiophobia
Baseline, mid-treatment, immediate post-treatment, 18-month follow-up
Blood sample
Time Frame: Baseline, immediate post-treatment, 18-month follow-up
  • CRP
  • TNF-alfa
  • lgF-1
  • Hb
  • HbA1C
  • s-cholesterol, HDL, LDL, s-triglycerids
  • K, Na
  • Creatinin, Leptin, Sysozym, n-terminal pBNP
Baseline, immediate post-treatment, 18-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pernilla Åsenlöf, Professor, Department of Neuroscience, Uppsala University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2010

Primary Completion (Actual)

March 1, 2012

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

April 12, 2010

First Submitted That Met QC Criteria

April 12, 2010

First Posted (Estimate)

April 13, 2010

Study Record Updates

Last Update Posted (Actual)

November 8, 2017

Last Update Submitted That Met QC Criteria

November 6, 2017

Last Verified

November 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Apnea, Obstructive

Clinical Trials on Behavioural strategies to promote physical activity and weight loss

Subscribe